PeerVoice Endocrinology & Metabolic Disorders Audio

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

http://www.peervoice.com

subscribe
share






Why Combination Therapies and Why Now? The Rationale and Role of GLP-1 RAs and Insulin


Visit https://www.peervoice.com/WBG860 to view the entire programme with slides. After completing “Why Combination Therapies and Why Now? The Rationale and Role of GLP-1 RAs and Insulin”, participants will be able to: Explain the rationale for combining GLP-1 receptor agonists (RAs) and basal insulin for patients with T2DM, based on mechanisms of action and recent guidelines; Evaluate the efficacy of combination therapy of GLP-1 RA and basal insulin on HbA1c, fasting and postprandial glucose, and other key glycaemic control measures; Discuss the most recent safety data for GLP-1 RAs, with a focus on hypoglycaemia, weight gain, and tolerability; Apply clinical data for combination therapy in the management of patients with T2DM in daily practice.


fyyd: Podcast Search Engine
share








 June 11, 2021  32m